Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Previous Article in Special Issue
Viruses 2010, 2(12), 2681-2695; doi:10.3390/v2122681
Review

Treatment of Vaccinia and Cowpox Virus Infections in Mice with CMX001 and ST-246

*  and
Received: 8 November 2010; in revised form: 6 December 2010 / Accepted: 6 December 2010 / Published: 13 December 2010
(This article belongs to the Special Issue Antivirals Against Poxviruses)
Download PDF [245 KB, uploaded 13 December 2010]
Abstract: Although a large number of compounds have been identified with antiviral activity against orthopoxviruses in tissue culture systems, it is highly preferred that these compounds have activity in vivo before they can be seriously considered for further development. One of the most commonly used animal models for the confirmation of this activity has been the use of mice infected with either vaccinia or cowpox viruses. These model systems have the advantage that they are relatively inexpensive, readily available and do not require any special containment facilities; therefore, relatively large numbers of compounds can be evaluated in vivo for their activity. The two antiviral agents that have progressed from preclinical studies to human safety trials for the treatment of orthopoxvirus infections are the cidofovir analog, CMX001, and an inhibitor of extracellular virus formation, ST-246. These compounds are the ones most likely to be used in the event of a bioterror attack. The purpose of this communication is to review the advantages and disadvantages of using mice infected with vaccinia and cowpox virus as surrogate models for human orthopoxvirus infections and to summarize the activity of CMX001 and ST-246 in these model infections.
Keywords: vaccinia virus; cowpox virus; murine model; orthopoxvirus; antiviral vaccinia virus; cowpox virus; murine model; orthopoxvirus; antiviral
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Quenelle, D.C.; Kern, E.R. Treatment of Vaccinia and Cowpox Virus Infections in Mice with CMX001 and ST-246. Viruses 2010, 2, 2681-2695.

AMA Style

Quenelle DC, Kern ER. Treatment of Vaccinia and Cowpox Virus Infections in Mice with CMX001 and ST-246. Viruses. 2010; 2(12):2681-2695.

Chicago/Turabian Style

Quenelle, Debra C.; Kern, Earl R. 2010. "Treatment of Vaccinia and Cowpox Virus Infections in Mice with CMX001 and ST-246." Viruses 2, no. 12: 2681-2695.



Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert